ScinoPharm Taiwan Ltd Cash Flow-to-Debt Ratio
ScinoPharm Taiwan Ltd cash flow-to-debt ratio. ScinoPharm Taiwan Ltd (1789) has a Cash Flow-to-Debt Ratio of 0.13x as of March 2026, meaning its operating cash flow of NT$199.47 Million could theoretically repay 0% of its total liabilities (NT$1.55 Billion) in one year. Check total reinvestment intensity of ScinoPharm Taiwan Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ScinoPharm Taiwan Ltd (2007–2025)
Cash flow-to-debt ratio of ScinoPharm Taiwan Ltd from 2007 to 2025. Historical debt coverage capacity for ScinoPharm Taiwan Ltd across 19 annual periods. Check ScinoPharm Taiwan Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
ScinoPharm Taiwan Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
ScinoPharm Taiwan Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for ScinoPharm Taiwan Ltd. For the full cash flow conversion analysis, see how efficiently does ScinoPharm Taiwan Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | NT$597.11 Million | NT$1.33 Billion | ▼ -15.5% |
| 2024 | 0.53x | NT$750.91 Million | NT$1.42 Billion | ▲ +211.2% |
| 2023 | 0.17x | NT$231.13 Million | NT$1.36 Billion | ▼ -67.8% |
| 2022 | 0.53x | NT$773.79 Million | NT$1.46 Billion | ▲ +22.6% |
| 2021 | 0.43x | NT$509.82 Million | NT$1.18 Billion | ▼ -39.9% |
| 2020 | 0.72x | NT$946.31 Million | NT$1.32 Billion | ▲ +28.8% |
| 2019 | 0.56x | NT$788.95 Million | NT$1.41 Billion | ▼ -8.3% |
| 2018 | 0.61x | NT$1.23 Billion | NT$2.02 Billion | ▲ +43.0% |
| 2017 | 0.43x | NT$971.71 Million | NT$2.28 Billion | ▼ -34.7% |
| 2016 | 0.65x | NT$1.67 Billion | NT$2.56 Billion | ▲ +47.5% |
| 2015 | 0.44x | NT$1.04 Billion | NT$2.36 Billion | ▼ -1.0% |
| 2014 | 0.45x | NT$888.29 Million | NT$1.99 Billion | ▼ -12.6% |
| 2013 | 0.51x | NT$939.47 Million | NT$1.84 Billion | ▼ -34.0% |
| 2012 | 0.77x | NT$981.55 Million | NT$1.27 Billion | ▼ -45.0% |
| 2011 | 1.41x | NT$1.29 Billion | NT$920.78 Million | ▼ -44.2% |
| 2010 | 2.52x | NT$1.56 Billion | NT$620.97 Million | ▲ +162.4% |
| 2009 | 0.96x | NT$1.30 Billion | NT$1.35 Billion | ▲ +58.3% |
| 2008 | 0.61x | NT$1.41 Billion | NT$2.32 Billion | ▲ +273.0% |
| 2007 | 0.16x | NT$504.50 Million | NT$3.10 Billion | — |